Skip to content
Clinical Trials – home
Verifiedinfo

Staedtisches Klinikum Braunschweig gGmbH

Germany Klinik für Allgemein- und Viszeralchirurgie, Salzdahlumer Strasse 90, 38126 Brunswick, Germany

  • 2 trials recruiting
  • Nephroblastoma · Pancreaticoduodenectomy · Acute myeloid leukaemia
  • Adults and children

About Specializations

Staedtisches Klinikum Braunschweig gGmbH in Brunswick, Germany specialises in clinical trials of conditions such as Nephroblastoma, Pancreaticoduodenectomy, Acute myeloid leukaemia, Trisomy 21, and other specialisations. This site conducts important research.

Main research areas of the site

Myeloid Leukemia in Children with Down Syndrome

The medical center is at the forefront of research in pediatric oncology, with a particular focus on myeloid leukemia in children with Down syndrome. This specialized area of study aims to improve outcomes for this unique patient population by exploring innovative treatment strategies.

  • Phase III Clinical Trials
  • Event-Free Survival (EFS) Metrics
  • Comparative Analysis with Historical Data

Through rigorous clinical trials, the center is dedicated to achieving an event-free survival rate that is comparable to previous benchmarks, thereby enhancing the quality of life and survival rates for affected children.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Klinik für Allgemein- und Viszeralchirurgie, Salzdahlumer Strasse 9038126 BrunswickGermany
Recruiting now
2 trials
Conditions studied
4
Partner status
Verified

More sites in BrunswickGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nicotine
  • Sponsor:Rheinische Friedrich-Wilhelms-Universitaet Bonn

Acute myeloid leukaemia+1

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Cytarabine
  • Sponsor:GPOH gGmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).